Date: September 20, 2023
Time: 7:00AM (EST)
Mintz member Terri Shieh-Newton will be participating on a panel entitled: "Regulatory Insights and Strategies for Platform Therapeutics" in conjunction with SynBioBeta.
Terri Shieh-Newton, PhD, is a Mintz Member who guides clients on portfolio management and landscape analysis. She's a trained immunologist with a PhD in Cellular and Molecular Medicine, and she works with companies of all sizes in a wide range of life sciences and clean technology industries.
Former Deputy Director, Office of Biotechnology Products, FDA
SVP Tech Ops and Manufacturing, bit.bio
Director, Human Health Content and Innovation, SynBioBeta